MDR Rule 8: Implantable Devices Default to Class IIb — Not Class III

Ask most device teams what class an implantable device gets under Regulation (EU) 2017/745, and the instinct answer is Class III. Rule 8 of Annex VIII says otherwise: the general default for implantable devices and long-term surgically invasive devices is Class IIb. Class III is not the baseline — it is reached through a specific, named set of exceptions, and the device types on that list (breast implants, surgical meshes, joint replacement implants, spinal disc replacement implants) are exactly the ones teams assume were already Class III for other reasons.

The default most teams skip past

Annex VIII of Regulation (EU) 2017/745 groups its invasive-device rules separately from its active-device rules, and Rule 8 sits in the invasive group: it reaches implantable devices and long-term surgically invasive devices as a category, not just the narrower set of active implantables most teams picture first. The rule's own baseline for that category is Class IIb. A device that is implantable, and does not fall within any of the rule's named exceptions, stays at Class IIb — the same class a long-term surgically invasive device without any of those features would get. Teams building a classification file for an implantable device who start from 'implants are Class III' are starting from the wrong default, not just skipping a step.

How a device actually reaches Class III under Rule 8

The escalation from the Class IIb default runs through conditions tied to where and how the device acts in the body, plus a named list of device types the rule calls out directly:

• Contact with the heart, central circulatory system, or central nervous system. Devices intended for direct contact with these sites move to Class III regardless of any other feature.
• Biological effect or absorption. A device intended to have a biological effect, or to be wholly or mainly absorbed by the body, is Class III — a test that turns on mechanism of action, not on the device's general invasiveness.
• Hazardous medicinal-product delivery. Implantable devices that administer a medicinal product by means of a delivery system are Class III where that administration is potentially hazardous given the mode of application.
• The named device list. Breast implants, surgical meshes, joint replacement implants, and spinal disc replacement implants or implantable devices in contact with the spinal column are classified Class III directly by name, with an exception carved out for ancillary components such as screws, wedges, plates, and instruments that accompany them.

The named list is where the default stops mattering. Once a device is a breast implant, a surgical mesh, a joint replacement, or a spinal implant, Rule 8 doesn't ask whether it's otherwise risky — it's already Class III. Why the device-type list deserves its own check

The boundary with active implantable devices

Rule 8 is frequently conflated with the rules governing active implantable medical devices, which MDR addresses chiefly through Rule 9 and the other active-device rules in Annex VIII. An implantable pacemaker lead or a powered neurostimulator is not working through Rule 8's Class IIb default and its exceptions — it is governed by the active-device framework, which carries its own classification logic. The practical risk is reversed from what teams expect: it is not that Rule 8 quietly pulls an active device down to Class IIb, but that a team analyzing a passive implant defaults to assuming Class III on instinct, without running the actual test the rule sets out, and without first confirming which rule governs the device at all. The MDCG 2021-24 classification guidance is the reference point for working through Annex VIII's rule set in order, rule by rule, rather than reasoning from a device category's reputation.

None of this is exotic once a team runs the rule in order instead of reasoning from reputation. It is a bounded piece of classification work: confirm Rule 8 (not Rule 9) governs the device, start from Class IIb, test the named escalation conditions against the device's actual mechanism and contact site, and check the device-type list independently of everything else. Teams that fold this into the same classification exercise that already covers Rule 22's diagnostic-function test and borderline and mode-of-action questions are the ones who reach conformity assessment with a classification file nobody has to relitigate.